CTO Dr. Jed Johnson recently spoke at the 26th annual Tampa Shoulder course.
Atreon Orthopedics has been invited to attend the prestigious AAOS Annual Meeting in Orlando, March 24-28.
Rotium Bioresorbable Wick receives FDA Clearance!
Today, Atreon Orthopedics announced that the U.S. Food and Drug Administration (FDA) has cleared its proprietary product, the Rotium Bioresorbable Wick, which is intended to be used in conjunction with suture anchors for the reattachment of tendon to bone in rotator cuff repairs
Rotium Bioresorbable Wick is a a non-woven, microfiber matrix comprising biodegradable polymer fibers that mimic the extracellular matrix structure. Rotium™ supports cellular infiltration and migration, and facilitates functional tissue regeneration.
